The pharmaceutical industry can singlehandedly shape government health policies with its vast influence networks Some companies steer research funding and public reimbursements toward their priciest treatments sometimes at the expense of patients health Does the pharmaceutical industrys total financialization of the drug ecosystem jeopardize the longevity of public health We investigate
